ArticleGynecologic oncology2018

Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials.

Emily Hinchcliff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.